Issaquah, WA, United States of America

Daniel R Leiske

This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel R Leiske. Retrieved from https://idiyas.com/inventor/daniel-r-leiske

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Daniel R Leiske

Introduction

Daniel R Leiske is an accomplished inventor based in Issaquah, WA (US). He has made significant contributions to the field of glycoprotein research, holding a total of 2 patents. His work focuses on manipulating glycan content, which is crucial for various biotechnological applications.

Latest Patents

Daniel's latest patents include a process for manipulating the level of glycan content of a glycoprotein. This invention provides a method for manipulating the fucosylated glycan content on a recombinant protein. This innovative approach has the potential to enhance the efficacy of therapeutic proteins.

Career Highlights

Daniel is currently employed at Amgen Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Amgen has allowed him to apply his expertise in glycoprotein manipulation to real-world applications, contributing to the development of advanced biopharmaceuticals.

Collaborations

One of Daniel's notable coworkers is Michael T Trentalange. Their collaboration has likely fostered a productive environment for innovation and research within their field.

Conclusion

Daniel R Leiske's contributions to glycoprotein research and his innovative patents highlight his role as a significant inventor in the biotechnology sector. His work continues to influence advancements in therapeutic protein development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…